These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 21251242

  • 21. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ, Foroozan R.
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [Abstract] [Full Text] [Related]

  • 22. Vigabatrin and epilepsy: lessons learned.
    Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E.
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [Abstract] [Full Text] [Related]

  • 23. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD, Tocher K, Acheson JF.
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [Abstract] [Full Text] [Related]

  • 24. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
    Kinirons P, Cavalleri GL, O'Rourke D, Doherty CP, Reid I, Logan P, Liggan B, Delanty N.
    Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
    [Abstract] [Full Text] [Related]

  • 25. Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy.
    Akçakaya AA, Gökçeer S, Erbil HH, Işik N, Ozdöker L, Salar S, Aykan F, Aydin T, Yaylali SA, Kesim O.
    Eur J Ophthalmol; 2010 Feb; 20(4):763-9. PubMed ID: 20155709
    [Abstract] [Full Text] [Related]

  • 26. [The function of eye and vision system in children and youth treated with vigabatrin--our own experiences].
    Pojda-Wilczek D, Emich-Widera E, Herba E, Pojda SM, Marszał E.
    Klin Oczna; 2005 Feb; 107(10-12):654-7. PubMed ID: 16619812
    [Abstract] [Full Text] [Related]

  • 27. The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication.
    Best JL, Acheson JF.
    Eye (Lond); 2005 Jan; 19(1):41-4. PubMed ID: 15094729
    [Abstract] [Full Text] [Related]

  • 28. Does the Swedish Interactive Threshold Algorithm (SITA) accurately map visual field loss attributed to vigabatrin?
    Conway ML, Hosking SL, Zhu H, Cubbidge RP.
    BMC Ophthalmol; 2014 Dec 23; 14():166. PubMed ID: 25539569
    [Abstract] [Full Text] [Related]

  • 29. Visual fields in young children treated with vigabatrin.
    Agrawal S, Mayer DL, Hansen RM, Fulton AB.
    Optom Vis Sci; 2009 Jun 23; 86(6):767-73. PubMed ID: 19417698
    [Abstract] [Full Text] [Related]

  • 30. VIGABATRIN TOXICITY IN INFANCY IS ASSOCIATED WITH RETINAL DEFECT IN ADOLESCENCE: A Prospective Observational Study.
    Wright T, Kumarappah A, Stavropoulos A, Reginald A, Buncic JR, Westall CA.
    Retina; 2017 May 23; 37(5):858-866. PubMed ID: 27552291
    [Abstract] [Full Text] [Related]

  • 31. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.
    Sergott RC, Bittman RM, Christen EM, Sagar SM.
    Epilepsy Res; 2010 Dec 23; 92(2-3):170-6. PubMed ID: 20951555
    [Abstract] [Full Text] [Related]

  • 32. [Visual field changes secondary to vigabatrin treatment].
    Mauri-Llerda JA, Iñiguez C, Tejero-Juste C, Santos-Lasaosa S, Escalza-Cortina I, Ascaso-Puyuelo J, Abad-Alegría F, Morales-Asín F.
    Rev Neurol; 2010 Dec 23; 31(12):1104-8. PubMed ID: 11205539
    [Abstract] [Full Text] [Related]

  • 33. Quantitative assessment of structural damage in eyes with localized visual field abnormalities.
    Bagga H, Greenfield DS.
    Am J Ophthalmol; 2004 May 23; 137(5):797-805. PubMed ID: 15126142
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vigabatrin and visual field defects in pediatric epilepsy patients.
    You SJ, Ahn H, Ko TS.
    J Korean Med Sci; 2006 Aug 23; 21(4):728-32. PubMed ID: 16891821
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nerve fiber layer thickness in glaucoma patients with asymmetric hemifield visual field loss.
    Badlani V, Shahidi M, Shakoor A, Edward DP, Zelkha R, Wilensky J.
    J Glaucoma; 2006 Aug 23; 15(4):275-80. PubMed ID: 16865002
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Vigabatrin-associated bilateral simple optic nerve atrophy with visual field constriction. A case report and a survey of the literature].
    Viestenz A, Viestenz A, Mardin CY.
    Ophthalmologe; 2003 May 23; 100(5):402-5. PubMed ID: 12748807
    [Abstract] [Full Text] [Related]

  • 40. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
    Mrugacz M, Bakunowicz-Łazarczyk A.
    Klin Oczna; 2003 May 23; 105(5):326-8. PubMed ID: 14746191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.